In a two-part conversation, learn how developers have approached different aspects of the manufacturing process to bring new and innovative treatments to patients. Register Now Featured sessions include: -
Part 1: BioNTech's Plans to Bring mRNA to the World
How can mRNA be manufactured in Africa? What are the logistical challenges of new, personalized mRNA cancer vaccines? A look at BioNTech's plans with Sierk Poetting, Ph.D., the company's chief operating officer. -
Part 2: BioMarin's Plans to Make a New Gene Therapy
BioMarin's hemophilia gene therapy, Roctavian, will present specific challenges when it comes to manufacturing. C. Greg Guyer, Ph.D., the chief technical officer and executive vice president of global manufacturing and technical operations, shares how the company has been investing in solutions. Register Now | |
No comments